Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Cannara Biotech Inc. secures an $80 million syndicated credit facility with BMO and TD Bank to enhance its financial capabilities and support ongoing growth initiatives.
PRIVATESep 10, 2026•about 2 hours ago
Amount Raised
$80 Million
Round Type
Debt Financing
Montreal
Investors
The Toronto Dominion BankBank Of Montreal
Description
Cannara Biotech Inc. has announced an expanded $80 million syndicated credit facility with Bank of Montreal and TD Bank. This new facility increases its total committed borrowing capacity by $30 million, refinances existing debts, and provides additional liquidity for working capital. With improved terms, it supports Cannara's continued capital investments in its Valleyfield facility
Company Information
Company
Cannara Biotech
Location
Montreal, Quebec, Canada
About
Cannara Biotech Inc. is a vertically integrated producer of high-quality cannabis and cannabis-derived products at affordable prices. The company operates two mega facilities in Quebec, totaling over 1,600,000 square feet, which allows for an annual potential production of 100,000 kg. Cannara leverages competitive energy costs to maintain a low-cost production model.
Don't miss Cannara Biotech's next move
Get an email the moment Cannara Biotech raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contactsZohar K., President and CEO hidden
Predictive Intelligence
Strategic
ML-powered predictions for Cannara Biotech's next move
Montreal